Cascade Investment Advisors, Inc. Gsk PLC Transaction History

Cascade Investment Advisors, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 Apr 15, 2019	SELL	$38.57 - $42.69 $312,417 - $345,789	-8,100 Closed	0 $0
Q4 2018 Jan 25, 2019	SELL	$37.8 - $42.69 $1.04 Million - $1.18 Million	-27,590 Reduced 77.3%	8,100 $310 Million
Q3 2018 Oct 12, 2018	BUY	$39.75 - $42.69 $12,918 - $13,874	325 Added 0.92%	35,690 $1.43 Billion
Q2 2018 Jul 31, 2018	SELL	$39.61 - $42.76 $253,305 - $273,450	-6,395 Reduced 15.31%	35,365 $1.43 Billion
Q1 2018 Apr 23, 2018	BUY	$36.18 - $40.15 $149,242 - $165,618	4,125 Added 10.96%	41,760 $1.63 Billion
Q4 2017 Jan 17, 2018	SELL	$35.34 - $41.9 $92,237 - $109,359	-2,610 Reduced 6.49%	37,635 $1.33 Billion
Q3 2017 Oct 12, 2017	BUY	$39.44 - $41.55 $1.59 Million - $1.67 Million	40,245	40,245 $1.63 Billion

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.4B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Cascade Investment Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Cascade Investment Advisors, Inc. with notifications on news.